BridgeBio Pharma Announces Filing of Registration Statement for Proposed Initial Public Offering
05.24.2019Eidos Therapeutics Reports Third Quarter 2018 Financial Results and Provides Corporate Update
11.06.2018Eidos Therapeutics to Host Conference Call and Webcast to Discuss Phase 2 Clinical Trial Results
10.29.2018
page of9
news archive
The press releases contained in this archive section are provided for historical purposes only. The information contained in each press release is accurate only as of the date each press release was originally issued. BridgeBio disavows any obligation to update the information contained in such press releases after the date of their issuance.